Show simple item record

dc.contributor.authorJacobs, BMen_US
dc.contributor.authorTaylor, Ten_US
dc.contributor.authorAwad, Aen_US
dc.contributor.authorBaker, Den_US
dc.contributor.authorGiovanonni, Gen_US
dc.contributor.authorNoyce, AJen_US
dc.contributor.authorDobson, Ren_US
dc.date.accessioned2020-07-14T10:20:25Z
dc.date.available2020-05-22en_US
dc.date.issued2020en_US
dc.identifier.otherARTN 119en_US
dc.identifier.otherARTN 119en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/65644
dc.relation.ispartofBRAIN COMMUNICATIONSen_US
dc.rightsThis is a pre-copyedited, author-produced version of an article accepted for publication in Brain Communications following peer review. The version of record: Benjamin M Jacobs, Thomas Taylor, Amine Awad, David Baker, Gavin Giovanonni, Alastair J Noyce, Ruth Dobson, Summary-data-based Mendelian randomization prioritizes potential druggable targets for multiple sclerosis, Brain Communications, Volume 2, Issue 2, 2020, fcaa119, https://doi.org/10.1093/braincomms/fcaa119 is available online at: https://doi.org/10.1093/braincomms/fcaa119
dc.subjectmultiple sclerosisen_US
dc.subjectMendelian randomizationen_US
dc.subjecttherapeuticsen_US
dc.titleSummary-data-based Mendelian randomization prioritizes potential druggable targets for multiple sclerosisen_US
dc.typeArticle
dc.identifier.doi10.1093/braincomms/fcaa119en_US
pubs.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000639431800060&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue2en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume2en_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record